Skip to main navigation
Overview
News
Events & Presentations
Events
Presentations
Financials
SEC Filings
Annual Reports
Stock Information
Stock Quote & Chart
Investor FAQs
Corporate Governance
Governance Documents
Committee Composition
Leadership
Code of Business Conduct
ESG Report
Corporate Responsibility
Contact the Board
Top bar
Biogen.com
Information Request
Sign up for Alerts
Search
Search
Search
News
Biogen Idec Presents 2012 Strategic Priorities at 30th Annual J.P. Morgan Healthcare Conference
News
Biogen Idec and Isis Pharmaceuticals Announce Global Collaboration for Antisense Program Targeting Spinal Muscular Atrophy
News
Biogen Idec to Present at the 30th Annual J.P. Morgan Healthcare Conference
News
Adaptive Phase II Study of BAN2401 in Early Alzheimer’s Disease Continues toward 18-Month Endpoint
News
Biogen to Report Fourth Quarter and Year-End 2017 Financial Results on January 25, 2018
News
Biogen and Ionis Enter into New Collaboration to Identify Novel Therapies for the Treatment of Spinal Muscular Atrophy
News
Biogen to Present at the 36th Annual J.P. Morgan Healthcare Conference
News
Biogen to Present at the Guggenheim 5th Annual Healthcare Conference
News
Biogen Appoints Mark Hernon as SVP, Chief Information Officer
News
Biogen and Alkermes Announce License and Collaboration Agreement to Develop and Commercialize ALKS 8700 for the Treatment of Multiple Sclerosis
Pagination
Page 1
Next page
››
Filter by gallery
No facets
Your selection
None
Filter by category
Filter by category
Filter by category
Filter by category
Filter by type
Filter by tags
Filter by form group
Filter by content year
2024
(89)
2023
(186)
2022
(187)
2021
(221)
2020
(136)
2019
(142)
2018
(152)
2017
(148)
2016
(164)
2015
(173)
2014
(160)
2013
(172)
2012
(167)
2011
(178)
2010
(180)
2009
(210)
2008
(246)
2007
(160)
2006
(132)
2005
(114)
2004
(180)
2003
(97)
2002
(21)
2001
(15)
2000
(22)
1999
(22)
1998
(19)
1997
(21)
1996
(19)
Filter by content type
SEC filing
(2539)
News
(1042)
Asset
(159)
Person
(48)
Landing page
(19)
Event
(15)
Governance committee
(3)
Basic page
(1)
Tools
Stockholder Communications
E-mail Alerts
Corporate Responsibility
FAQs
Facebook
Twitter
LinkedIn
Google+